Laurus Synthesis
Laurus Generics GMBH
Laurus Generics IncCatalogue of all regulatory announcements and official press releases
25 Apr 2024
Outcome of the Board Meeting – April 25, 2024
25 Apr 2024
Corporate Action - 02nd Interim Dividend for FY 2023-24
25 Apr 2024
Laurus Labs Financial Results Q4 FY 2024 Press Release
18 Apr 2024
Board Meeting Intimation
18 Apr 2024
Q4 & FY 24 Earnings conference call invite
13 Apr 2024
Incorporation of a Joint Venture Company in India
30 Mar 2024
Laurus Labs Q4 Trading Window Closure 2023-24
17 Feb 2024
Update on Investment in M/s. Immunoadoptive Cell Therapy Private Limited
23 Jan 2024
Grant of Stock Options to the eligible employees
27 Dec 2023
Closure of Trading Window
08 Dec 2023
Allotment of Equity Shares on exercise of ESOPs
21 Nov 2023
Update on acquisition of shares of Laurus Bio Private Limited
20 Oct 2023
Mrs. Sreelakshmi Form C
20 Oct 2023
Change in Directorate
20 Oct 2023
Outcome of the Board Meeting – October 20, 2023
20 Oct 2023
Corporate Action – Interim Dividend for FY 2023-24
16 Oct 2023
Update on acquisition of shares of Laurus Bio Private Limited
29 Sep 2023
Laurus Labs Q2 Trading Window Closure 2023-24
11 Sep 2023
Outcome of the Board Meeting dated September 11, 2023
21 Jul 2023
Q1 FY 24 Earnings conference call invite
20 Jul 2023
Laurus Labs Limited Board Meeting On July 27, 2023
14 Jul 2023
Proceedings of 18th Annual General Meeting
12 Jul 2023
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 dated May
31, 2023
29 Jun 2023
Update on Credit Rating – Disclosure under Regulation 30 of SEBI (LODR)
Regulations, 2015
26 Jun 2023
Update on Credit Rating – Disclosure under Regulation 30 of SEBI (LODR)
Regulations, 2015
16 Jun 2023
Newspaper Advertisement
20 May 2023
Investors Group Meeting May 20, 2023
27 Apr 2023
Corporate Action Agm 2023
27 Apr 2023
Corporate Action 02nd Interim Dividend For FY 2022-23
21 Apr 2023
Laurus Labs Q4 Full Year FY23 result con call invite
19 Apr 2023
Laurus Labs Limited Board Meeting April 27, 2023
31 Mar 2023
Laurus Labs Q4 Trading Window Closure
13 Mar 2023
Investors Group Meeting March 13, 2023
10 Mar 2023
Postal ballot e-voting Results and Scrutinizer Report
06 Feb 2023
Antique Conference
30 Jan 2023
Postal Ballot Notice to Stock Exchanges
30 Jan 2023
Postal Ballot Notice dated January 30,2023
30 Jan 2023
Outcome of the Board Meeting – January 30, 2023
21 Jan 2023
Laurus Labs Limited Board Meeting On January 30, 2023
21 Jan 2023
Laurus labs ltd. Q3 & 9m fy23 results conference call on monday, 30th january 2023 at 5.00 p.M. (IST)
31 Dec 2022
Closure of Trading Window
17 Dec 2022
Allotment of Equity Shares on exercise of ESOPs
03 Nov 2022
Disclosure under Regulation 30 of SEBI (LODR) Regulations
2015
21 Oct 2022
Laurus Labs outcome of BM October 21, 2022 Corporate Action
21 Oct 2022
Laurus Labs Outcome Ocotber 21, 2022
13 Oct 2022
Laurus Labs Limited Board Meeting On October 21, 2022
13 Oct 2022
Laurus Labs Q2 & 1H FY 23 result con call invite
29 Sep 2022
Laurus Labs Q2 Trading Window Closure 2022-23
22 Aug 2022
Stock Ex
Intimation Meeting Aug 24 2022FINAL
21 Jul 2022
Laurus
labs ltd. Q1 FY 23 results conference call on
thursday, july 28, 2022 at 11:00 am IST
19 Jul 2022
Board Meeting Intimation
30 Jun 2022
Grant of Stock Options to
the eligible employees
30 Jun 2022
Proceedings of 17111
Annual General Meeting
29 Jun 2022
Q1 Trading
Window Closure
09 Jun 2022
Newspaper Advertisement
02 Jun 2022
Newspaper Advertisement
11 May 2022
Disclosure
of Related Party Transactions for the half
year ended March 31, 2022
11 May 2022
Annual
Secretarial Compliance Report for the year
ended March 31, 2022
29 Apr 2022
Laurus Labs Q4 FY 22
Earnings Conference Call
29 Apr 2022
Audio
Recording of the Q4 & Full Year FY22 Results
conference call hosted on April 29, 2022
28 Apr 2022
Corporate
Action -02nd Interim Dividend for FY 2021-22
28 Apr 2022
AGM Book Closure FY 2022
28 Apr 2022
AGM Time Change
28 Apr 2022
Initial
Disclosure under SEBI circular
SEBI/HO/DDHS/CIRJP/2018/144 dated November 26, 2018
25 Apr 2022
Laurus Labs Ltd. Q4 & Full
Year Fy22 Results Conference
Call
20 Apr 2022
Board Meeting Intimation
07 Apr 2022
Annual
Declaration - SAST Reg 31(4)
30 Mar 2022
Laurus Labs
Q4 Trading Window Closure 2021-22
22 Mar 2022
Jayasree
Form C - 7686 - Buy
14 Mar 2022
Update on schedule of the
Analyst/ Institutional
Investor Meetings
11 Mar 2022
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
28 Feb 2022
Yamini Form
C - 2275 Sale
28 Feb 2022
Madhuri
Form C - 10K Purchase
21 Feb 2022
Intimation of Schedule of
Analyst/ Institutional
Investor Meetings
10 Feb 2022
Disclosure
under Regulation 30 of LODR Regulations,
2015, as amended
07 Feb 2022
Intimation of Schedule of
Analyst/ Institutional
Investor Meetings
21 Jan 2022
LAURUS LABS
LTD. Q3 & 9M FY22 RESULTS CONFERENCE CALL
ON FRIDAY
19 Jan 2022
Laurus Labs
Limited Board Meeting On January 27,
2022
30 Dec 2021
Laurus Labs
Q3 Trading Window Closure 2021-22
20 Dec 2021
Allotment of Equity Shares
on exercise of ESOPs
15 Dec 2021
Chandra
kumari Form C 10245 pledg Dec -15,2021
09 Dec 2021
Disclosure
under Regulation 30 of the SEBI (LODR)
Regulations, 2015 dated November 19,2021
19 Nov 2021
Disclosure
of Related Partv Transactions for the half
vear ended September 30, 2021
17 Nov 2021
SEBI SAST
Regulation 29(2) Mrs. Nagarani
17 Nov 2021
SEBI SAST
Regulation 29(2) Dr. Satya
17 Nov 2021
NSN
Holdings disclosure 29(1) Part-A
15 Nov 2021
NSN
Holdings - Disclosure under Reg 10(6) of SAST
08 Nov 2021
NSN
Holdings - Disclosure under Reg 10(5) of SAST
28 Oct 2021
Corporate
Action - Interim Dividend for FY 2021-22
28 Oct 2021
Outcome of the Board
Meeting - October 28, 2021
21 Oct 2021
Laurus Labs
Q2 FY 22 result con call invite
20 Oct 2021
Laurus Labs
Limited Board Meeting On October 28, 2021
30 Sep 2021
Laurus Labs
Q2 Trading Window Closure
17 Sep 2021
Vijaya
Kumari Form C 12K Sale
17 Sep 2021
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
13 Sep 2021
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
07 Sep 2021
Srilakshmi
Form C 5000 Sale
02 Sep 2021
AYalamanchi
Rama Form C 5500 Sale
13 Aug 2021
Anil Form C
3000 Sale
11 Aug 2021
SS Rao Form
C 85777 Sale
11 Aug 2021
Srinivasa
Rao S Form C 20000 Sale
10 Aug 2021
Madhuveer
Form C 1445 Sale
26 Jul 2021
Laurus Labs
Q1 FY 22 results con call invite
19 Jul 2021
Laurus Labs
Q1 FY 21-22 Board Meeting July 29, 2021
15 Jul 2021
Proceedings of 16th Annual
General Meeting
07 Jul 2021
Girish
Kotapalli Form C 15000 Sale
07 Jul 2021
Narasimha
Form C PC and Buy
02 Jul 2021
Venkateswara Rao K Form C
20K PR
01 Jul 2021
Kranthi
Form C 1750 Sale
01 Jul 2021
Phanindra
Form C 3825 Sale
01 Jul 2021
Narendra
Dev Form C 966 Sale
01 Jul 2021
PK Nandi
Form C 30K Sale
01 Jul 2021
Sreelakshmi
Form C 8000 Sale
01 Jul 2021
Som Parkash
Form C 15000 Sale
01 Jul 2021
Satish
Kommineni Form C 4000 Sale
01 Jul 2021
Sandhya
Rani Form C 2100 Sale
01 Jul 2021
Mohana Form
C 5000 Sale
01 Jul 2021
Prathima
Chava Form C 1.45 L Sale
30 Jun 2021
Surendra
Nath Form C PR and Sale
30 Jun 2021
Jagan
Mohana Rao Koya Form C 45K PR and
Sale
30 Jun 2021
Closure of
Trading Window
29 Jun 2021
Prasad PKV
Form C - 65K PC
29 Jun 2021
Giridhar
Form C - 65K PC
29 Jun 2021
Murali
Mohan P Form C - 35k PC
28 Jun 2021
SS Rao Form
C - 2.2L PC
28 Jun 2021
Srinivas
Simhadri Form C 13000 Sale
28 Jun 2021
Sita
Ramaiah Form C - 35000 Sale
28 Jun 2021
GV Reddy
Form C - 2000 Sale
25 Jun 2021
Radha
Krishna Form C - 37500 PR
25 Jun 2021
Ratna
Kumari Form C - 17500 PR
24 Jun 2021
Ravindra
Aduri Form C 15000 Pledge
24 Jun 2021
Naveen
Kumar Form C 5000 Sale
24 Jun 2021
Nagi Reddy
Form C 2470 Sale
24 Jun 2021
Upgradation
in Credit Rating- Disclosure under
Regulation 30 of SEBI (LODR) Regulations, 2015
22 Jun 2021
VRN
Chowdary Form C 20K Pledge
22 Jun 2021
Venkata
Subbarao Form C 900 Sale
22 Jun 2021
Pavan Kumar
J Form C 8.5K Pledge
22 Jun 2021
AGM Advertisement
18 Jun 2021
Srinivasa
Rao Buddi Form C 2457 Buy
15 Jun 2021
Pavan
Elisett -Form C 3465 Sale
15 Jun 2021
Mohana
Bikkani Form C 849 Sale
15 Jun 2021
Loka
Nagabushan Rao Form C 2375 Sale
14 Jun 2021
Dr.
Lakshman Form C 17L Pledge Release
11 Jun 2021
Suneetha
Nair Form C 5665 Sale
10 Jun 2021
Venkata
Subbarao Form C 3000 Sale
10 Jun 2021
JN Rao Form
C 5000 Sale
10 Jun 2021
Ravi Kumar
V V Form C 4L Sale
09 Jun 2021
Dr.
Lakshman Rao C V Form C 4L Sale
09 Jun 2021
Jagan
Mohana Rao K Form C 25000 Sale
09 Jun 2021
GV Reddy
Form C 3000 Sale
09 Jun 2021
Dr. Samatha
Form C 1700 Sale
09 Jun 2021
Narendra
Babu T Form C 2810 Sale
09 Jun 2021
Narendra
Dev V Form C 2200 Sale
09 Jun 2021
Babchand
Form C 10000 Sale
09 Jun 2021
Babchand
Form C 20000 Sale
08 Jun 2021
Sumanth K
Form C 2700 Sale
07 Jun 2021
Babchand N
Form C 10000 Sale
07 Jun 2021
Pre AGM
Notice FY 2020-21
03 Jun 2021
Babchand
Form C 10000 Sale
02 Jun 2021
D MVG Rao
Form C 2600 Buy
02 jun 2021
Dr.
Ravindra Aduri Form C 4376 Sale
01 Jun 2021
VNVPRASAD
Form C 17000 Pledge
31 May 2021
Amarchand
Form C 3750 Sale
31 May 2021
Madhuveer
Form C 2000 Sale
28 May 2021
Tejavathi
Form C 3810 Sale
28 May 2021
Mohana Form
C 2151 Sale
28 May 2021
Babchand
Form C 10000 Sale
26 May 2021
Mani Bushan
K Form C 10000 Sale
25 May 2021
Narendra
Dev Form C 4500 Sale
24 May 2021
Veeraiah
Form C 5000 Sale
21 May 2021
Sridhar
Shyam Form C 4300 Sale
21 May 2021
Satish Form
C 8139 Buy
18 May 2021
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
13 May 2021
Meher Form
C 5400 Sale
13 May 2021
Ravi Varma
Form C 8160 Pledge/a>
12 May 2021
Veeraiah
Form C 3510 Sale
11 May 2021
Pavan E
Form C 8418 Sale
11 May 2021
Rajesh
Nallani Form C 6440 Pledge
11 May 2021
Murali
Apparaju Form C 11000 Sale
05 May 2021
Suresh Form
C 9100 - Sale
05 May 2021
GVR Form C
5500 - Sale
04 May 2021
Jagan Form
C Sale - 75500
04 May 2021
Navneet
Mehta Form C Sale - 10000
04 May 2021
Srinivas
Form C 3000 - Sale
29 Apr 2021
Disclosure
for a Large Corporate Entity
29 Apr 2021
Corporate Action -3rd
Interim Dividend for FY
2020-21
29 Apr 2021
Grant of Stock Options to
the eligible employees
29 Apr 2021
Outcome of the Board
Meeting - Apri129, 2021
26 Apr 2021
Laurus Labs Ltd. Q4 & Fy21
Results Conference Call On
Friday, April 30, 2021 At 11:00 Am IST
22 Apr 2021
Board
Meeting Intimation
01 Apr 2021
Form C Mr.
Sunder
30 Mar 2021
Laurus labs
Q4 Trading Window Closure
23 Mar 2021
Revision in
Credit Rating - Disclosure under Regulation
30 of SEBI (LODR) Regulations, 2015
18 Mar 2021
Form C
Chandra Kumari
12 Mar 2021
Form C Mr.
Satish
12 Mar 2021
SEBI-SAST-Regulation
31(1)(2)-5750000 -
Dr. Satya Pledge Release Bajaj Finance
12 Mar 2021
SEBI-SAST
Regulation 31(2)(2)-5750000 -
Dr. Satya Pledge Release Tata Capital
12 Mar 2021
SEBI-SAST
Regulation 31(1)(2)-6575000 -
Dr. Satya Pledge Release AXIS FINANCE
12 Mar 2021
SEBI-SAST
Regulation 31(2)(2)-800000 -
Dr. Lakshma Pledge Release Adity
12 Mar 2021
Form C
Pledge Release Dr. Satya
12 Mar 2021
Form C
Pledge Release Dr. Lakshman
11 Mar 2021
Form C Mrs.
Nagarani Chava Pledge Release 3750000
12 Mar 2021
SEBI-SAST
Regulation 31(1)(2)-3750000 -
Mrs. Nagarani Pledge Release AXIS FINANCE
09 Mar 2021
Form C
Krishna Kishore JVV
09 Mar 2021
Form C Dr.
Ravindra Aduri
08 Mar 2021
Form C Mr.
Vijay Krosuri
08 Mar 2021
Form C Mr.
DVL Narasimha Rao
04 Mar 2021
Form C Mr.
Madhusudan Reddy
04 Mar 2021
Form C 18L
S Mrs. Nagarani
04 Mar 2021
Form C 52L
S Dr. Satya
17 Feb 2021
Analyst
Investor Meetings
16 Feb 2021
Form C
Ravikrishna Chebolu
10 Feb 2021
Update on
Acquisition of stake in Richcore Lifesciences
Private Limited
09 Feb 2021
Form C Mrs.
Mahalakshmi M
09 Feb 2021
Form C Dr.
MVG Rao
06 Feb 2021
Form C Mrs.
Mahalakshmi Malempati
06 Feb 2021
Form C Dr.
MVG Rao
04 Feb 2021
Form C Dr.
MVG Rao
03 Feb 2021
Form C Mr.
PKVPrasad
03 Feb 2021
Form C Mr.
Satish
03 Feb 2021
Form C Mr.
Babchand N
02 Feb 2021
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
01 Feb 2021
Form C Mr.
Krishna Kishore JVV
28 Jan 2021
Outcome of
the Board Meeting - January 28, 2021
28 Jan 2021
Corporate
Action -2nd Interim Dividend for FY
2020-21
20 Jan 2021
Update on
Acquisition of stake in Rich core
Lifesciences Private Limited
19 Jan 2021
Laurus Labs
Limited Board Meeting On 28.01.2021
11 Jan 2021
Disclosure
under Regulation 30 of the SEBI (LODR)
Regulations, 2015 - incorporation of Step-Down Subsidiary
02 Jan 2021
Form C Dr.
Uttam
31 Dec 2020
Form C M.
Giridhar
31 Dec 2020
Form C Dr. Samatha
30 Dec 2020
Laurus Labs
Q3 Trading Window Closure
29 Dec 2020
Form C Mr.
Sridhar Shyam
28 Dec 2020
Mr and Mrs.
Satyanarayana Tinnaluri
Form C
22 Dec 2020
Form C
ESOPS
22 Dec 2020
Allotment
of Equity Shares on exercise of ESOPs
18 Dec 2020
Form C Smt.
Sarada Kurapati
10 Dec 2020
Form C Dr
Satya
09 Dec 2020
SEBI-SAST
Regulation
31(1)(2)-2200000-Dr. Satya-Pledge Release - AXIS FINANCE
09 Dec 2020
SEBI-SAST
Regulation 31(1)(2)-1100000
Dr. Satya-Pledge Release - AXIS FINANCE
09 Dec 2020
SEBI-SAST
Regulation 31(1)(2)-1100000
Dr. Satya-Pledge Creation - AXIS FINANCE
09 Dec 2020
SEBI-SAST
Regulation 31(1)(2)-1750000
Dr. Satya-Pledge Release - TATA CAPITAL
09 Dec 2020
Form C Dr
Satya
08 Dec 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
07 Dec 2020
Form C Mr.
PKV Prasad
04 Dec 2020
Form C
Naveen Kumar V
02 Dec 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
02 Dec 2020
Form C Dr.
Vaidyanathan Iyer Narayana
Swamy
26 Nov 2020
Conference
Call of Laurus Labs Ltd’s Acquisition of
Richcore Lifesciences Pvt. Ltd.
25 Nov 2020
Investors/
Analysts Presentation
25 Nov 2020
Laurus Labs
Ltd. Acquires Majority Stake In Richcore
Lifesciences Conference Call On Thursday
23 Nov 2020
Form C Mr.
Jagan Mohan
23 Nov 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
19 Nov 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
19 Nov 2020
Form C S
srinivasaRao
19 Nov 2020
Form C Mr.
Chandrakanth
13 Nov 2020
Form C Mr.
Pavan Kumar Nerella
12 Nov 2020
Form C Mr.
Pavan Kumar Nerella
11 Nov 2020
Form C Mr.
Murali Krishna
11 Nov 2020
Form C Mr.
Chandrakanth
10 Nov 2020
Form C Mr.
Krishna Chaitanaya
09 Nov 2020
Form C Mr.
Harikrishna K
09 Nov 2020
Form C Mr.
Sita Ramaiah
07 Nov 2020
Form C Mr.
Chandrakanth
04 Nov 2020
Form C Ms.
Soumya
04 Nov 2020
Form C Mr.
Chandrakanth
29 Oct 2020
Laurus Labs
Corporate Action -Interim Dividend for FY
2020-21
29 Oct 2020
Laurus Labs
Approval Letter for reclassification of
Shareholding from Promoter Category to Public Category
29 Oct 2020
Laurus Labs
Outcome of the Board Meeting 29.10.2020
26 Oct 2020
LAURUS LABS
LTD Q2 & H1 FY21 results conference
call
19 Oct 2020
Laurus Labs
Limited Board Meeting On 29.10.2020
29 Sep 2020
Form C Ms.
Rochana Devi R
29 Sep 2020
Closure of
Trading Window
28 Sep 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
28 Sep 2020
From C Ms. Deepthi
25 Sep 2020
Form C Mr. CNR
23 Sep 2020
From C Dr.
Radha Krishna S Spouse PLedge
23 Sep 2020
From C Dr.
Radha Krishna S Spouse BUY
22 Sep 2020
Form C
Narendra Kumar K
22 Sep 2020
Form C
dated 22.09.2020 Dr. Satya Pledge Release
22 Sep 2020
Form C
dated 22.09.2020 Mrs. Nagarani
Pledge Release
22 Sep 2020
SEBI SAST
Regulation 31(1)(2)-225000
Dr. Satya Pledge Release AXIS
22 Sep 2020
SEBI SAST
Regulation 31(1)(2)-750000
Mrs. Nagarani Pledge Release AXIS
21 Sep 2020
From C Mr.
Tirumal Reddy
21 Sep 2020
Form C Mr.
Srinivasa Rao Suryadevara
21 Sep 2020
Form C Dr. Uttam
16 Sep 2020
Form C
dated16.09.2020 Dr. Satya Pledge Release
16 Sep 2020
SEBI SAST
Regulation 31(1)(2) - 650000
Dr. Satya Pledge Release
16 Sep 2020
From C Dr.
Radha Krishna S Spouse
12 Sep 2020
From C Dr.
Radha Krishna S
10 Sep 2020
Form C Dr.
Lakshman Rao CV
10 Sep 2020
Form C Mr.
Satyanarayana Goud K
08 Sep 2020
Form C Mr.
Babchand 08.09.2020 Pledge Release
07 Sep 2020
Form C
Mudit Singhal
04 Sep 2020
Form C Mr.
Babchand
03 Sep 2020
Form C Mrs.
S. Rama
02 Sep 2020
Form C Mr.
Sita Ramaiah
02 Sep 2020
Form C Mr.
Ramakrishna BV
02 Sep 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
28 Aug 2020
Form C Ms.
Vamsi Rekha
27 Aug 2020
Form C Mr.
Rajesh Nallani
18 Aug 2020
Intimation
of Schedule of Analyst/ Institutional
Investor Meetings
18 Aug 2020
Form C Mr.
Ramakrishna Rao K
18 Aug 2020
Form C Ms.
Santhi Wo Dr. UMA
17 Aug 2020
From C Dr. MVG Rao
12 Aug 2020
Form C
dated 12.08.2020 Dr. Satya
Pledge Release and Creation
12 Aug 2020
SEBI SAST
Regulation 31(1)(2) - 1500000
Dr. Satya Pledge Creation - TATA
12 Aug 2020
SEBI SAST
Regulation 31(1)(2) - 500000
Dr. Satya Pledge Release - BAJAJ
12 Aug 2020
SEBI SAST
Regulation 31(1)(2) - 1560000
Dr. Satya Pledge Release - AXIS
10 Aug 2020
Form C Mr.
Murali Apparaju
10 Aug 2020
Form C Mr.
Suresh Babu M
10 Aug 2020
Form C
Mudit Singhal
08 Aug 2020
Form C Mr. P K Nandi
30 Jul 2020
Laurus Labs
Outcome of the Board Meeting
30 Jul 2020
Laurus Labs
Split Corporate Action
29 Jul 2020
SEBI SAST
Regulation 31(1)(2)-2500000
Dr. Satya
29 Jul 2020
Form C
dated 29.07.2020 Dr. Satya
27 Jul 2020
Laurus Labs
Investor Call
24 Jul 2020
SEBI SAST
Dr. SATYA
24 Jul 2020
Form C 24.07.2020
21 Jul 2020
Laurus Labs
Board Meeting Intimation Q12020-21
20 Jul 2020
Laurus Labs
Application to Stock
Exchanges for Reclassification
17 Jul 2020
Form C ESOP
16 Jul 2020
Laurus Labs
ESOP Allotment JULY 2020
14 Jul 2020
Form C Mr.
Vijay Prakash
11 Jul 2020
Evoting
Results 15th AGM
10 Jul 2020
Report on
Voting Results of 15th Annual
General Meeting
09 Jul 2020
Proceedings
of 15th Annual General
Meeting
09 Jul 2020
Reclassification of
Promoter Category
of Dr.Raju
04 Jul 2020
Laurus Labs
Update on Acquisition NAME CHANGE
01 Jul 2020
Laurus Labs
Addendum to AGM Notice 2020
01 Jul 2020
Laurus Labs
Update on Acquisition
01 Jul 2020
Laurus Labs
Mr. Narendra Ostawal Resignation
01 Jul 2020
Disclosure
Reg 29(2)-Bluewater Investment
30 Jun 2020
SEBI-SAST
Regulation
31(1)(2)-2500000-Dr Satya-Pledge Release
30 Jun 2020
SEBI-SAST
Regulation
31(1)(2)-2500000-Dr Satya-Pledge Creation
30 Jun 2020
Form C Mr.
Chandrakanth
30 Jun 2020
Form C
dated 30.06.2020 Mr. CNR
30 Jun 2020
Form C
dated 30.06.2020 Dr. Satya-Pledge Release
30 Jun 2020
Form C
dated 30.06.2020 Dr. Satya-Pledge Creation
30 Jun 2020
Laurus Labs
Q1 Trading Window Closure 2020-21
26 Jun 2020
Form C Dr.
Lakshman
26 Jun 2020
Form C Mr.
Jagan
25 Jun 2020
Form C Mr.
Jagan
25 Jun 2020
Form C Mr.
Chandrakanth
18 Jun 2020
SAST Declaration Dr.
Satyanarayana C
18 Jun 2020
SAST Declaration Mrs.
Nagarani
18 Jun 2020
Form
C Mrs. Nagarani
18 Jun 2020
Form C Dr. Satyanarayana C
15 Jun 2020
Laurus Labs
AGM Notice FY 2019-20
06 Jun 2020
Laurus Labs
News paper Advertisement
28 May 2020
Laurus Labs
outcome of Board Meeting
Corporate Action
27 May 2020
Disclosure
to stock exchanges COVID19
27 May 2020
Laurus Labs
RPT Disclosure March 2020
14 May 2020
Form C
14.05.2020
12 May 2020
Disclosure
Reg 29(2) SEBI (SAST) Reg.2011 ERML
11 May 2020
Disclosure
Reg 29(2) SEBI (SAST) Reg.2011
09 May 2020
Form C 09.05.2020
30 Apr 2020
Outcome of
Board Meeting 30.04.2020
27 Apr 2020
Laurus Labs
Con Call 30.04.2020
24 Apr 2020
Laurus Labs
Board Meeting Intimation
06 Apr 2020
Form C 06.05.2020
06 Apr 2020
Declaration
Reg 31 SAST 2011-31.03.2020
06 Apr 2020
Disclosure
Reg 30 SAST 2011-31.03.2020
31 Mar 2020
Form C
dated 31.03.2020
31 Mar 2020
Form C
31.03.2020
31 Mar 2020
SEBI-SAST
Regulation 31(1)(2) 2000000
31 Mar 2020
Form C 31.03.2020
31 Mar 2020
SEBI-SAST
Regulation 31(1)(2) 250000
31 Mar 2020
Laurus Labs
Q4 Trading Window Closure 2019-20
30 Mar 2020
Form C
dated 30.03.2020
26 Mar 2020
Form C
dated 26.03.2020
20 Mar 2020
Form C
dated 25.03.2020
20 Mar 2020
Laurus Labs
Furtherance Letter
20 Mar 2020
SEBI SAST
REGULATION 31(1)(2) 2750000
20 Mar 2020
Form C
20.03.2020
20 Mar 2020
Form C
20.03.2020
20 Mar 2020
Form C
20.03.2020
18 Mar 2020
Form C 18.03.2020
17 Mar 2020
Form C 17.03.2020
12 Mar 2020
Laurus Labs
out come of Board Meeting 12.03.2020
12 Mar 2020
Laurus Labs
outcome of Board Meeting Corporate Action
12.03.2020
04 Mar 2020
Laurus Labs
Board Meeting On March-12 04.03.2020
29 Feb 2020
Intimation
of Resignation of Independent Director of
the Company 29.02.2020
21 Feb 2020
Analyst
Investor Meet Intimation 21.02.2020
14 Feb 2020
Form C
Regulation 7(2) 14.02.2020
11 Feb 2020
Form C
11.02.2020
06 Feb 2020
Form C
06.02.2020
27 Jan 2020
Laurus Labs
Con Call invite Q3 2019-20
23 Jan 2020
Laurus Labs
Receives EIR from USFDA
31 Dec 2019
Laurus Labs
Board Meeting Intimation Q3 2019-20
31 Dec 2019
Form C
31.12.2019
31 Dec 2019
Form C
31.12.2019
31 Dec 2019
Form C
31.12.2019
31 Dec 2019
Form C 31.12.2019
31 Dec 2019
Form C
31.12.2019 Hyderabad
31 Dec 2019
Form C
Pledge 31.12.2019
31 Dec 2019
SEBI SAST
Regulation 31(1)(2) Dr. Lakshman
31 Dec 2019
Laurus Labs
Trading Window Closure Q3
27 Dec 2019
Form C
27.12.2019
26 Dec 2019
Form C
26-12-2019
26 Dec 2019
Letters for
Reclassification
24 Dec 2019
Regulation
7(2) - Dr.Raju 24-12-2019
24 Dec 2019
Form C
24-12-2019
23 Dec 2019
Form C 23-12-2019
23 Dec 2019
SEBI-SAST
Regulation 31(1)(2)-90000-Dr.Lakshman
18 Dec 2019
Form C
18-12-2019
16 Dec 2019
Laurus Labs
ESOP Grants
07 Dec 2019
Change of
Name of Share Transfer Agent
27 Nov 2019
Form C
27-11-2019
25 Nov 2019
Form C
25-11-2019
25 Nov 2019
Analyst
Investor Meet Intimation
06 Nov 2019
Laurus Labs
RPT Disclosure
29 Oct 2019
Laurus
Labs Con Call Invite Q2 2019-20 Results
21 Oct 2019
Laurus
Labs Board Meeting Intimation 31 10 2019
01 Oct 2019
Form C
01-10-2019
30 Sep 2019
Laurus Labs
trading Window Closure Q2
27 Sep 2019
Form C
27-09-2019
26 Oct 2019
Form C - ESOP 2019
24 Sep 2019
Laurus
Labs ESOPs Allotment 2019
24 Sep 2019
SEBI-SAST
Regulation 31(1)(2)-100000-Dr Lakshman
24 Sep 2019
Form C
24-09-2019
21 Sep 2019
Form C
21-09-2019
19 Sep 2019
Form C
19-09-2019
08 Sep 2019
Laurus
Labs Disclosure Reg 30
Acquisition of Foreign entity in South Africa
06 Sep 2019
Form C 06
Sep 2019
21 Aug 2019
Laurus
Labs Intimation of Analyst
Investor Call
16 Aug 2019
Form C 16
Aug 2019
09 Aug 2019
Form C 09
Aug 2019
30 July 2019
Laurus
Labs Q1 FY2020 Results Conference Call
24 July 2019
Board
Meeting Intimation
12 July 2019
Proceedings
of 14th Annual General Meeting
12 July 2019
Results of
Voting- 14th Annual General Meeting
29 June 2019
Disclosure
under Reg 30(1) & 30(2) of
SAST Reg 2011.
29 June 2019
Closure of
Trading Window.
29 June 2019
Disclosure
under Regulation 7(2) of
SEBI (PIT) Regulations 2015 .
31 May 2019
Form C 31
May 2019.
31 May 2019
Disclosure
on Related Party Transactions.
17 May 2019
Form C.
14 May 2019
Certificate
under Regulation 74(5) of the SEBI
Regulations 2018.
3 May 2019
Q4 FY19
Conference Call Transcript.
30 Apr 2019
LAURUS LABS
LTD. Q4 & FY19 RESULTS CONFERENCE CALL
30 Apr 2019
Not-applicability of Large
Corporate
Criteria.
25 Apr 2019
Board
Meeting
4 Apr 2019
Closure of
Trading Window
2 Apr 2019
Disclosure
under Regulation 30 of SEBI
Regulations 2011
28 Mar 2019
Disclosure
by the promoter(s) to stock
exchanges and to the target company for encumbrance of shares
18 Mar 2019
FIL Capital
Disclosure
18 Feb 2019
Disclosure
under Regulation 7(2) read
with Regulation 6(2) of SEBI (PIT) Regulations 2015
14 Feb 2019
Disclosure
under Regulation 7(2) read
with Regulation 6(2) of SEBI (PIT)
Regulations 2015
1 Feb 2019
Q3 FY19
Conference Call Transcript
1 Feb 2019
Laurus Labs
Q3 & 9M FY19 results
concall invite
23 Jan 2019
Board
Meeting Intimation
2 Jan 2019
LaurusLabs
Disclosure under Reg7(2)of
SEBI(PIT) Reg 2015 02 Jan 2019
20 Dec 2018
LaurusLabs
Granting of Stock Options to
The Eligible Employees
15 Dec 2018
LaurusLabs
Disclosure under Reg7(2)of
SEBI(PIT) Reg 2015 15 Dec, 2018
27 Nov 2018
Laurus Labs
Disclosure under Reg 7(2)
of SEBI(PIT) 2015 27 Nov,2018
15 Nov 2018
LaurusLabs
Disclosure under Reg7(2) of
SEBI(PIT) Reg 2015 15 Oct,2018
2 Nov 2018
Q2 FY19
Conference Call Transcript
10 Nov 2018
Disclosure
under Reg 30(1) & 30(2) of
SAST Reg 2011 Dr Satya
10 Nov 2018
Disclosure
under Reg 30(1) & 30(2) of
SAST Reg 2011 Ms Nagarani
8 Nov 2018
Laurus Labs
Disclosure under Reg7(2) of
SEBI(PIT) Reg2015 08 Oct, 2018
3 July 2018
Disclsoure
under Reg7(2) of SEBI(PIT)
Regulations 2015
2 Nov 2018
Disclsoure
under Reg7(2) of SEBI(PIT)
Regulations 2015
2 Nov 2018
Laurus Labs
Q2 & H1 FY 19 Results
ConCall Invite
26 Oct 2018
Disclsoure
under Reg 7(2) of SEBI (PIT)
Regulations 2015 - 26 Oct, 2018
23 Oct 2018
Board
Meeting Intimation
11 Oct 2018
Disclsoure
under Reg7(2) of SEBI (PIT)
Regulations 2015 11-10-2018
06 Oct 2018
Disclsoure
under Reg7(2) of SEBI(PIT)
Regulations 2015 - 06 Oct 2018
28 Sep 2018
Disclsoure
under Reg7(2) of
SEBI(PIT)Regulations 2015 28-09-2018
25 Sep 2018
Disclsoure
under Reg7 (2) of SEBI (PIT)
Regulations 2015 25 Sep 2018
24 Sep 2018
Disclsoure
under Reg7(2) of SEBI(PIT)
Regulations 2015
20 Sep 2018
Laurus Labs
Intimation of Allotment of
Sharesunder ESOP Schemes
21 Aug 2018
Disclosure
under Reg-7(2) readd with
Reg-6(2) of PIT Reg2015 21-Aug-2018
14 Aug 2018
SEBI SAST
Reg 31 (1) & (2) - 14.08.2018
13 Aug 2018
Disclosure
under Reg-7(2) readd with
Reg-6(2) of PIT Reg 2015 13 Aug
9 Aug 2018
Disclosure
under Reg 7(2) readd with
Reg 6(2) of PIT Reg 2015
4 Aug 2018
Laurus Labs
Q1 FY19 Conference Call
Transcript
4 Aug 2018
Laurus Labs
Q1 FY19 Results Conference
Call Intimation
26 July 2018
Board
Meeting Intimation 3rd August
2018
6 July 2018
Results of
Voting 13th Annual General
Meeting
6 July 2018
Proceedings
of 13th Annual General Meeting
6 July 2018
Disclosure
under Reg 7(2) readd with
Reg 6(2) of PIT Reg 2015 - July6 2018
29 June 2018
Disclosure
under Regulation Regulations
7(2) read with Regulation 6(2) of SEBI (PIT) 2015
7 June 2018
Disclosure
under Regulation Regulations
7(2) read with
Regulation 6(2) of SEBI (PIT) 2015 (June 7, 2018)
6 June 2018
SEBI SAST
Reg 31 of (1) (2) 6240000
5 June 2018
Disclosure
under Regulation 7(2) read
with Regulation 6(2) of SEBI (PIT)
Regulations 2015
30 May 2018
SEBI-SAST
Reg 31 of (1) (2) - 2790000
31 May 2018
Disclosure
under Regulation 7(2) read
with Regulation 6(2) of SEBI (PIT)
Regulations 2015
30 May 2018
Disclosure
under Regulation 7(2) read
with Regulation 6(2) of SEBI (PIT)
Regulations 2015
29 May 2018
Disclosure
under Regulation 7(2) read
with Regulation 6(2) of SEBI (PIT)
Regulations 2015
11 May 2018
Laurus
Labs Q4 FY18 Conference Call Transcript
10 May 2018
Outcome of
Board Meeting (May 10,2018)
10 May 2018
Laurus Labs
Q4 FY18 Results Conference
Call Invitation May 11 2018
10 May 2018
Board
Meeting Intimation 10th May
2018
10 April 2018
Reporting
under Regulation 29(1)of
SEBI-SBI Mutual Funds 10-04-2018
05 April 2018
Disclosure
Under Reg(30) of
SEBI(SAST)Regulations 2011
31 March 2018
Disclosure
under Reg 7(2) of SEBI(PIT)
Regulations 2015
8 March 2018
Change in
Directorate Appointment of Dr
Lakshmana Rao CV
8 March 2018
Resignation
of Dr. Srihari Raju
Kalidindi
28 February 2018
Analyst -
Investor - Meet Intimation
28-02-2018
30 January 2018
Conference
Call Transcript Jan 30, 2018
30 January 2018
Laurus Labs
Q3 9M FY18 Results
Conference Call Invitation (Jan 30, 5 PM)
19 January 2018
Board
Meeting Intimation 29th January
2018
26 December 2017
Disclosure
under Reg 7(2) of SEBI (PIT)
Regulations 2015 Mr.S.Sathyanarayana 26-12-2017
21 December 2017
Disclosure
under Reg 7(2) of SEBI (PIT)
Regulations 2015 Mr.N.Babchand 19-12-2017
4 December 2017
Analyst -
Investor - Meet - Intimation
04-12-2017
30 November 2017
Laurus Labs
receives maiden Tentative
Approval from USFDA for Tenofovir Disoproxil Fumarate Tablets
24 November 2017
Resignation
of Mr. Rajesh Kumar Dugar,
Director of Laurus Labs
10 November 2017
Conference
Call Transcript
10-11-2017
14 November 2017
Laurus Labs
received the EIR for its
Units 1 & 3
1 November 2017
Board Meeting Intimation
18 November 2017
Disclosure
under Regulation 7(2)
Regulation 6(2) of SEBI(PIT) Regulations 2015
11 October 2017
Analyst
Investor Meet – Intimation
12-10-2017
21 September 2017
Allotment of
Equity Shares on exercise
of ESOPs
15 September 2017
Unit 2
receives EIR from USFDA and
completes German Regulatory Authority inspection; WHO inspections
completed for Unit 1 & 3
29 August 2017
Intimation
of Schedule of Analyst/
Institutional Investor Meetings on August 29, 2017
11 August 2017
Q1 & FY 2018 Results:
Analyst & Investor Call
(Aug 11, 2 PM)
1 August 2017
Intimation
of Board Meeting
13 July 2017
Proceedings
of AGM 12-07-2017
13 July 2017
AGM Voting
Results 12-07-2017
19
May
2017
Unit 2
USFDA Audit Successful
18
May
2017
Q4 & FY
2017 Results: Investor
Presentation
18
May
2017
Outcome of
Board Meeting (May 18)
19
May
2017
Q4 & FY
2017 Results: Analyst &
Investor Call (May 19)
9
February
2017
Q3 & FY
2017 Results: Investor Presentation
8
May
2017
Announcement
8
May
2017
Intimation
of Board Meeting
8
May
2017
Intimation
of Demise of Director
27 March 2017
Resignation
of Director - Reg
11 March 2017
Disclosures
under Regulation 30 of the
SEBI
1
March
2017
Disclosure
under Reg 7(2) of SEBI (PIT)
Regulations 2015 01-03-2017
10
February
2017
Intimation
of Conference Call
2
February
2017
Board
meeting Intimation for Results
& Closure of Trading Window
2
January
2017
Resignation
of Director-Conner Town
Mulvee
29 December 2016
Change of
CIN - Reg
23
December
2016
Disclosure
under Reg 7(2) of SEBI (PIT)
Regulations 2015_23-12-2016
20 December 2016
Reporting
under Regulation 29(1) of
SEBI
25 Jan 2024
Press Release - JV Agreement with KRKA
24 Jan 2024
Press Release - Laurus Labs Financial Results Q3 FY 2024
20 Oct 2023
Press Release - Financial Results Q2 FY 2024
27 Jul 2023
Press Release - Financial Results Q1 FY 2024
22 Jun 2023
Press Release - Newspaper Advertisement
27 Apr 2023
Laurus Labs Financial Results Q4 FY 2023 Press Release
30 Jan 2023
Laurus Labs Financial Results Q3 FY 2023 Press Release
21 Oct 2022
Laurus Labs Financial Results Q2 FY 2023 Press Release
27
Jul 2022
Laurus Labs
Financial Results Q1 FY 2023 Press Release
28
Apr 2022
Press
Release - Q4 Press Release FY 2022
27
Nov 2021
Press
Release -Laurus Labs Financial
Results Q3 FY 2022
28
Oct 2021
Healthy
Growth momentum with 17% revenue growth for
H1FY22
29
Jul 2021
Press
Release -Laurus Labs Financial Results Q1 FY
2022
29
Apr 2021
Laurus
Labs Financial Results Q4 FY 2021 Press
Release
20
Feb 2021
Laurus Labs wins coveted
Golden Peacock Award for
Excellence in Corporate Governance
28
Jan 2021
Revenue
growth of 76% and PAT growth of 274% in Q3
FY21
29
Oct 2020
Laurus
Labs Press Release Board Meeting Oct 29
2020
29
Oct 2020
Q2 H1 FY21
Press Release Oct 29 2020
30
Jul 2020
Press
Release - Strong Revenue growth of 77% and PAT
growth
of 1047%
19
May 2020
Press
Release - Laurus Labs receives USFDA approvals
for
ANDAs TLE 400 and TLE 600 tablets.
30
Apr 2020
Press
Release - Highest Ever Profit
after
Tax at INR 2,553 mn in FY20, growth of 172%
30
Jan 2020
Press
Release - PROFIT AFTER TAX AT INR 73.5 crs in Q3
FY20
with a growth of 313 %
08
Nov 2019
Laurus Labs
completed the USFDA Inspection of its FDF &
API
Integrated Facility, Unit 2, at Visakhapatnam
30
Oct 2019
Laurus Labs
Financial Results Q2 FY 2020 Press Release
18
Sep 2019
Laurus Labs
to acquire the Subsidiary Company of Aspen
Pharmacare, South Africa
02
Aug 2019
Q1 FY20
Results: Revenues up by 2
percent
22
July 2019
Laurus
Labs' exclusive distribution partner Rising
Pharmaceuticals, launches Pregabalin Capsules in US market
12
July 2019
Laurus Labs
completed the US FDA inspection of Unit 4
at
Visakhapatnam
14
June 2019
USFDA
inspection of API facilites Unit 1 & 3 at
Visakhapatnam
2
May 2019
FY 19 :
Laurus Labs revenues up by 11.5 percent in Q4
26
Mar 2019
FY 19 :
Laurus Labs enters into strategic partnership
agreement with the Global Fund
11
Mar 2019
FY 19 :
Laurus Labs receives two approvals from USFDA
3
Feb 2019
FY 19 :
Laurus Labs received tentative approval from
USFDA
under PEPFAR for TLD
FDC
3
Feb 2019
FY 19 :
USFDA Approval for TLD Tablets
and
EIR from USFDA
31
Jan 2019
FY 19 :
Laurus Labs Revenue Grew 11% in Q3 FY19
1
Nov 2018
FY 18 :
Laurus Labs Financial Results Q2 FY2019 Press
Release
23
Oct 2018
FY 18 : Press Release Laurus Labs Oct 23 2018
29
Aug 2018
FY 18 : Press Release 29 Aug 2018 - Metformin USFDA Approval
3
Aug 2018
FY 18 : Press Release of Q1 Results 2018-19
10
May 2018
FY 17 : Press Release of Q4 Results 2017-18
1
March 2018
FY 17 : Intimation of completion of USFDA inspection of unit2 with no
observations
29
January 2018
FY 17 : Press Release of Q3 9M Results 2017-18
17
January 2018
FY 17 : LAURUS LABS CERTIFIED AS THE “GREAT PLACE TO WORK” IN THE LARGE
SIZED ORGANISATIONCATEGORY
IN
INDIA
9
November 2017
FY 17 : Q2 H1 Results 2017-18 Press Release
10
November 2017
FY 17 : Analyst and Investor Meet Intimation 10-11-2017
15 September
2017
FY 17 : Unit 2 receives EIR
from USFDA and completes
German
Regulatory Authority inspection; WHO inspections completed for Unit 1
& 3
18 August
2017
FY 17 : Laurus Labs
completed the USFDA inspection of
its
API facilities Unit 1 & 3 at Visakhapatnam
10 August
2017
FY 17 :
Press Release of Q1 Results 2017-18
5 July
2017
FY 17 :
Laurus Labs Credit Rating
Improved
18 May
2017
FY 17 :
Laurus Labs PAT grows by 40%
9 February
2017
FY 17 :
Laurus Labs demonstrates strong
Q3
growth In the first quarterly results after successful IPO
07 Feb 2022
Newspaper Publication - Postal Ballot Notice
31 Jan 2023
Q3 FY 2022-23 Results Announcement - Business Standard
31 Jan 2023
Q3 FY 2022-23 Results Announcement - Prajasakthi
22 Oct 2022
Q2 FY 2022-23 Results Announcement - Business Standard
22 Oct 2022
Q2 FY 2022-23 Results Announcement - Prajasakthi
28 Jul 2022
Q1 FY 2022-23 Results Announcement - Business Standard
28 Jul 2022
Q1 FY 2022-23 Results Announcement - Prajasakthi
09 Jun 2022
Annual
Report and Notice Business Standard
09 Jun 2022
Annual
Report and Notice Prajasakti
02 Jun 2022
Pre AGM
Notice 2021-22 Business Standard
02 Jun 2022
Pre AGM
Notice 2021-22 Prajasakti
12 May 2022
2nd Interim Dividend TDS
exemption Declaration Business
Standard
12 May 2022
2nd Interim
Dividend TDS exemption Declaration
Prajasakti
29 Apr 2022
Q4
FY 2021-22 Results Announcements Business Standard
29 Apr 2022
Q4 FY 2021-22 Results
Announcements Prajasakti
22 Jun 2021
AGM Notice
FY 2020-21 Business
Standard
22 Jun 2021
AGM Notice
FY 2020-21 Prajasakthi
07 Jun 2021
Pre AGM
Notice FY 2020-21
Prajasakti
07 Jun 2021
Pre AGM
Notice FY 2020-21 Business
Standard
14 May 2021
3rd Interim
Dividend TDS exemption
Declaration prajasakti
14 May 2021
3rd Interim
Dividend TDS exemption
Declaration Business Standard
30 Apr 2021
Q4 FY
2020-21 3rd interim Dividend
Record
date Business Standard
30 Apr 2021
Q4 FY
2020-21 Results Announcements
Prajasakti
30 Apr 2021
Q4 FY
2020-21 Results Announcements
Business Standard
24 Apr 2021
Q4 FY
2020-21 Board Meeting Notice
Prajasakti
24 Apr 2021
Q4 FY
2020-21 Board Meeting Notice
Business
Standard
11 Feb 2021
2nd Interim
Dividend TDS exemption
Declaration prajasakti
11 Feb 2021
2nd Interim
Dividend TDS exemption
Declaration Business Standard
29 Jan 2021
Q3 FY
2020-21 Results Announcements
Prajasakthi
29 Jan 2021
Q3 FY
2020-21 Results Announcements
Business Standard
20 Jan 2021
Q3 FY
2020-21 Board Meeting Notice
Prajasakti
20 Jan 2021
Q3 FY
2020-21 Board Meeting Notice
Business
Standard
13 Nov 2020
Interim
Dividend TDS exemption
Declaration
-Business Standard
13 Nov 2020
Interim
Dividend TDS exemption
Declaration
- Prajasakthi
30 Oct 2020
Interim
Dividend Record Date
publication -
Business Standard
30 Oct 2020
Q2 FY
2020-21 Results Announcements -
BusinessStandard
30 Oct 2020
Q2 FY
2020-21 Results Announcements -
Prajasakthi
20 Oct 2020
Q2 FY
2020-21 Board Meeting Notice -
Business Standard
20 Oct 2020
Q2 FY
2020-21 Board Meeting Notice -
Prajasakthi
31 Jul 2020
Q1 FY
2020-21 Results Announcements -
Business Standard
31 Jul 2020
Q1 FY
2020-21 Results Announcements -
Prajasakthi
22 Jul 2020
Q1 FY
2020-21 Board Meeting Notice -
Business Standard
22 Jul 2020
Q1 FY
2020-21 Board Meeting Notice -
Prajasakthi
02 Jul 2020
Addendum to
AGM Notice FY 2019-20 -
Business Standard
02 Jul 2020
Addendum to
AGM Notice FY 2019-20 -
Prajasakthi
15 Jun 2020
AGM Notice
FY 2019-20 - Business
Standard
15 Jun 2020
AGM Notice
FY 2019-20 - Prajasakthi
04 Jun 2020
Pre AGM
Notice FY 2019-20 - Business
Standard
04 Jun 2020
Pre AGM
Notice FY 2019-20 -
Prajasakthi
01 May 2020
Q4 FY
2019-20 Results Announcements -
Business Standard
01 May 2020
Q4 FY
2019-20 Results Announcements-
Prajasakthi
28 Apr 2020
Q4
FY 2019-20 Board Meeting Notice- Business Standard
28 Apr 2020
Q4 FY
2019-20 Board Meeting
Notice-Prajasakthi
13 Mar 2020
Interim
Dividend Record Date
publication -
Business Standard
13 Mar 2020
Interim
Dividend Record Date
publication -
Prajasakthi
31 Jan 2020
Q3 FY
2019-20 Results Announcement -
Business Standard
31 Jan 2020
Q3 FY
2019-20 Results Announcement -
Prajasakthi
21 Jan 2020
Q3 FY
2019-20 Board Meeting Notice -
Business Standard
21 Jan 2020
Q3 FY
2019-20 Board Meeting Notice -
Prajasakthi
01 Nov 2019
Q2 FY
2019-20 Results Announcement -
Business Standard
01 Nov 2019
Q2 FY
2019-20 Results Announcement -
Prajasakthi
22 Oct 2019
Q2 FY
2019-20 Board Meeting Notice -
Business Standard
22 Oct 2019
Q2 FY
2019-20 Board Meeting Notice -
Prajasakthi
03 Aug 2019
Q1 FY
2019-20 Results Announcement -
Business Standard
03 Aug 2019
Q1 FY
2019-20 Results Announcement -
Prajasakthi
25 July 2019
Q1 FY
2019-20 Board Meeting Notice -
Business Standard
25 July 2019
Q1 FY
2019-20 Board Meeting Notice -
Prajasakthi
18 June 2019
14th AGM
Notice FY 2018-19 - Business
Standard
18 June 2019
14th AGM
Notice FY 2018-19 -
Prajasakthi
03 MAY 2019
Q4 FY
2018-19 Results Announcement -
Business Standard
03 May 2019
Q4 FY
2018-19 Results Announcement -
Prajasakthi
26 April 2019
Q4 FY
2018-19 Board Meeting Notice -
Business Standard
26 April 2019
Q4 FY
2018-19 Board Meeting Notice -
Prajasakthi
01 Feb 2019
Q3 FY
2018-19 Results Announcement -
Business Standard
01 Feb 2019
Q3 FY
2018-19 Results Announcement -
Prajasakthi
24 Jan 2019
Q3 FY
2018-19 Board Meeting Notice -
Business Standard
24 Jan 2019
Q3 FY
2018-19 Board Meeting Notice -
Prajasakthi
02 Nov 2018
Q2 FY
2018-19 Results Announcement -
Business Standard
02 Nov 2018
Q2 FY
2018-19 Results Announcement -
Prajasakthi
24 Oct 2018
Q2 FY
2018-19 Board Meeting Notice -
Business Standard
24 Oct 2018
Q2 FY
2018-19 Board Meeting Notice -
Prajasakthi
04 Aug 2018
Q1 FY
2018-19 Results Announcement -
Business Standard
04 Aug 2018
Q1 FY
2018-19 Results Announcement -
Prajasakthi
27 July 2018
Q1 FY
2018-19 Board Meeting Notice -
Business Standard
27 July 2018
Q1 FY
2018-19 Board Meeting Notice -
Prajasakthi
12 June 2018
13th AGM
Notice FY 2017-18 - Business
Standard
12 June 2018
13th AGM
Notice FY 2017-18 -
Prajasakthi
11 May 2018
Q4 FY
2017-18 Results Announcement -
Business Standard
11 May 2018
Q4 FY
2017-18 Results Announcement -
Prajasakthi
03 May 2018
Q4 FY
2017-18 Board Meeting Notice -
Business Standard
03 May 2018
Q4 FY
2017-18 Board Meeting Notice -
Prajasakthi
20 Jan 2018
Q3 FY
2017-18 Board Meeting Notice -
Business Standard
20 Jan 2018
Q3 FY
2017-18 Board Meeting Notice -
Prajasakthi
30 Jan 2018
Q3 FY
2017-18 Results Announcement -
Business Standard
30 Jan 2018
Q3 FY
2017-18 Results Announcement -
Prajasakthi
10 Nov 2017
Q2 FY
2017-18 Results Announcement -
Business Standard
10 Nov 2017
Q2 FY
2017-18 Results Announcement -
Prajasakthi
02 Nov 2017
Q2 FY
2017-18 Board Meeting Notice -
Business Standard
02 Nov 2017
Q2 FY
2017-18 Board Meeting Notice -
Prajasakthi
11 Aug 2017
Q1 FY
2017-18 Results Announcement -
Business Standard
11 Aug 2017
Q1 FY
2017-18 Results Announcement -
Prajasakthi
02 Aug 2017
Q1 FY
2017-18 Board Meeting Notice -
Business Standard
02 Aug 2017
Q1 FY
2017-18 Board Meeting Notice -
Prajasakthi
17 June 2017
12th AGM
Notice FY 2016-17 - Business
Standard
17 June 2017
12th AGM
Notice FY 2016-17 -
Prajasakthi
19 May 2017
Q4 FY
2016-17 Results Announcement -
Business Standard
19 May 2017
Q4 FY
2016-17 Results Announcement -
Prajasakthi
11 May 2017
Q4 FY
2016-17 Board Meeting Notice -
Business Standard
11 May 2017
Q4 FY
2016-17 Board Meeting Notice -
Prajasakthi
10 Feb 2017
Q3 FY
2016-17 Results Announcement -
Business Standard
10 Feb 2017
Q3 FY
2016-17 Results Announcement -
Prajasakthi
03 Feb 2017
Q3 FY
2016-17 Board Meeting Notice -
Business Standard
03 Feb 2017
Q3 FY
2016-17 Board Meeting Notice -
Prajasakthi
- Dr. M Venu Gopala Rao
-
Non-Executive Chairman/Independent Director
- Dr. Chava Satyanarayana
-
CEO/Executive Director
- Dr. Lakshman Chunduru
-
Executive Director – Quality
- Mr. Venkata Ravi Kumar Vantaram
-
CFO/ Executive Director
- Mrs. Aruna Bhinge
-
Non-Executive Director/Independent Director
- Mr. Rajesh Koshy Chandy
-
Non-Executive Director/Independent Director
- Dr. Ravindranath Kancherla
-
Non-Executive Director/Independent Director
Biodiversity & No-deforestation Policy
Business Code of Conduct and Ethics Policy
Policy of Prohibition of Child, Adolescent, Forced Labour
Business Code of Conduct and Ethics Policy
Criteria for determining materiality of events
Code for Prohibition of Insider Trading
Corporate Social Responsibility Policy
Familiarization Programmes for Independent Directors
Policy on Materiality of Subsidiaries
Related Party Transactions Policy
